Quantum BioPharma Ltd.
QNTM
$30.18
$4.4517.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 69.31% | 104.90% | 51.04% | -41.30% | -77.33% |
| Total Receivables | -50.03% | -48.67% | 56.65% | 123.74% | 916.65% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -31.59% | -65.76% | -50.78% | -64.15% | -66.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2,652.29% | 2,791.21% | -66.11% | -- | -69.13% |
| Total Current Assets | 8.06% | 8.73% | 49.72% | 10.05% | -14.36% |
|
|
|||||
| Total Current Assets | 8.06% | 8.73% | 49.72% | 10.05% | -14.36% |
| Net Property, Plant & Equipment | 4.00% | 8.31% | 1.10% | -58.82% | -52.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.01% | -7.88% | -7.72% | -7.58% | -49.85% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -88.04% |
| Total Assets | -3.66% | -2.03% | 0.45% | -28.78% | -47.63% |
|
|
|||||
| Total Accounts Payable | -49.67% | 0.44% | -49.36% | -7.79% | -22.30% |
| Total Accrued Expenses | 55.27% | 16.01% | 88.89% | -42.13% | -84.59% |
| Short-term Debt | 81.35% | 105.99% | 0.00% | 104.86% | 99.63% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 704.60% | 432.04% | 16.37% | -91.04% | -83.13% |
| Total Finance Division Other Current Liabilities | 83,741.25% | 4,666.77% | -99.92% | -100.00% | -98.22% |
| Total Other Current Liabilities | 83,741.25% | 4,666.77% | -99.92% | -100.00% | -98.22% |
| Total Current Liabilities | 163.62% | 46.29% | -12.25% | -13.75% | -54.37% |
|
|
|||||
| Total Current Liabilities | 163.62% | 46.29% | -12.25% | -13.75% | -54.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 81.35% | 105.99% | 0.00% | 104.86% | 99.63% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 163.62% | 46.29% | -12.25% | -13.89% | -54.50% |
|
|
|||||
| Common Stock & APIC | 9.33% | 8.06% | 7.29% | 2.44% | 1.28% |
| Retained Earnings | -13.06% | -8.99% | -6.55% | -4.84% | -6.60% |
| Treasury Stock & Other | -45.80% | -34.77% | -16.33% | -31.33% | -28.96% |
| Total Common Equity | -52.35% | -13.27% | 9.80% | -29.53% | -42.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -52.35% | -13.27% | 9.80% | -29.53% | -42.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -133.42% | -217.65% | -955.08% | -- | -- |
| Total Equity | -60.67% | -19.13% | 4.06% | -34.39% | -44.79% |
|
|
|||||